{"schema_version":"secwatch.filing_event.v1","accession":"0001539497-22-001158","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.754903+00:00","generated_at":"2026-06-25T02:42:28.346924+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bioxytran announces PCT publication of two COVID-19 treatment patents and USPTO trademark approval for ProLectin","bullets":["PCT published patent WO 2022/099052 for polysaccharides treating SARS-CoV-2, filed Nov 2021.","PCT published patent WO 2022/099061 for IV-administered pectin polysaccharides treating SARS-CoV-2.","USPTO approved trademark 'ProLectin' for publication in Trademark Official Gazette on June 28, 2022.","Both patents claim priority date of November 6, 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001539497-22-001158","json":"https://secwatch.observer/filing/0001539497-22-001158.json","markdown":"https://secwatch.observer/filing/0001539497-22-001158.md","text":"https://secwatch.observer/filing/0001539497-22-001158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/0001539497-22-001158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000153949722001158/n2583_x45-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:42:28.346924+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}